Home›Stock Screener›Sunrest Lifescience

Sunrest Lifescience Share Price Today | Stock Price & Sunrest Lifescience Share Screener

SUNREST Pharmaceuticals & Biotechnology

Track the current Sunrest Lifescience share price and stock price live with TickJournal's free stock screener. Track SUNREST market value to gauge the company's total market size. Use the Sunrest Lifescience stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sunrest Lifescience opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Sunrest Lifescience Market Cap ₹71.75 Cr.
SUNREST P/E Ratio (TTM) -
Sunrest Lifescience P/B Ratio 0.80
EPS (TTM) ₹9.59
Dividend Yield -
Debt to Equity 0.80
SUNREST 52 Week High -
Sunrest Lifescience 52 Week Low -
Operating Margin -
Profit Margin -
SUNREST Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹71.00
Total Equity ₹30.00

Sunrest Lifescience Share Price Chart

Track the current stock price of Sunrest Lifescience with an interactive chart. Analyse SUNREST share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sunrest Lifescience stock quote in one place.

Sunrest Lifescience Company Profile - Fundamental Screener

Screen Sunrest Lifescience company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUNREST shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0PLZ01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0PLZ01012

Sunrest Lifescience Balance Sheet Screener

Screen SUNREST balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹71, up from ₹59 in 2025.

Latest statistics put total assets at ₹71 and shareholder funds at ₹30, with a leverage ratio of 0.80.

Item 2026 2025

Assets

Total Assets 71 59
Current Assets 0 0
Fixed Assets 9 4

Liabilities

Total Liabilities 0 0
Current Liabilities 12 6
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 30 22
Share Capital 4 4
Reserves & Surplus 16 12

Sunrest Lifescience Income Statement Screener - Profit & Revenue Analysis

Screen Sunrest Lifescience income statement and profit fundamentals. Analyze SUNREST quarterly results. Sunrest Lifescience reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹73 and net profit of ₹8.

Item None-None 2026-March 2025-March

Revenue and Expenses

Revenue 0 73 33
Expenses 0 61 30

Operating Costs and Margins

EBITDA 0 13 3
Operating Profit % 0.00% 14.00% 9.00%
Depreciation 0 1 0
Interest 0 1 0

Profit and Earnings

Profit Before Tax 0 10 3
Tax 0 2 1
Net Profit 0 8 2
EPS 0.00 9.59 4.67

Sunrest Lifescience Cash Flow Screener - Liquidity Fundamentals

Screen SUNREST cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹3 and financing activities provided ₹4.

Item 2026-March 2025-March

Cash from Operations and Investing

Operating Activities 0 3
Investing Activities -3 -1

Financing and Net Cash

Financing Activities 4 0
Net Cash Flow 1 2

Sunrest Lifescience Shareholding Pattern Screener

See Sunrest Lifescience shareholding pattern with promoter, FII, and DII holdings. Check Sunrest Lifescience promoter holding and ownership changes for SUNREST on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 53.50%, foreign institutions 0.00%, domestic institutions 0.00% and the public 35.87%, spread across 484 shareholders.

The shareholder count was 484 in 2026-Sept, compared with 484 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 53.50% 53.50% 53.50% 53.50% 53.50% 69.91% 69.91% 69.91%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 35.87% 36.02% 36.35% 34.90% 36.02% 24.27% 24.94% 24.83%
Other Holding 10.63% 10.48% 10.14% 11.60% 10.48% 5.82% 5.15% 5.26%
Shareholder Count 484 484 492 491 498 455 459 487

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sunrest Lifescience. Sunrest Lifescience dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Sunrest Lifescience.

Sunrest Lifescience Stock Index Membership - Nifty & Sensex

See which indices include Sunrest Lifescience stock. Check SUNREST index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sunrest Lifescience is not part of any tracked indices.
Only major market indices are tracked in our system.

Sunrest Lifescience Market Events Screener - Corporate Actions

Get Sunrest Lifescience corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sunrest Lifescience stock events that may affect SUNREST share price, along with derivatives, futures and options activity and sector gainers.

6 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Quarterly Result Announcement dated May 29, 2026 and Quarterly Result Announcement dated November 13, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -8.28%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -2.78%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 1.51%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -7.88%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 1.51%
2024-09-28 2024-09-28 Annual General Meeting NA -1.55%

Sunrest Lifescience Competitors Screener - Peer Stocks Comparison

Screen SUNREST competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,724 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,573 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,518 84.70 13,886 20.34% 2,138 47.23
Laurus Labs 125,785 94.90 6,868 22.01% 890 57.04
Zydus Life Science 119,720 27.90 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 116,438 42.00 35,059 3.90% 4,158 71.26
Cipla 115,346 39.20 29,045 2.24% 3,870 53.06
Mankind Pharma 108,689 47.50 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,792 25.90 34,145 5.56% 3,503 60.39
Lupin 89,949 17.10 29,039 26.75% 5,356 39.39

Sunrest Lifescience Company Announcements - News & Reports Screener

Screen SUNREST latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 0.80. Market capitalisation stands at ₹71.75 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 19, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.